Immunosuppressant Tablet Franchise in Ahmedabad

Immunosuppressant Tablet Franchise in Ahmedabad

Azathioprine 100 mg Tablet Supplier in Mumbai

Autoimmune Disorder Tablet Distributor in Delhi

Immunosuppressive Medicine Supplier in Hyderabad
Azathioprine Tablet Exporter in Chandigarh

Home/Products /azathioprine-100mg-tablet

Azathipair 100 Tablet

Composition : Azathioprine 100mg Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹0/-

Azathipair 100 Tablet contains Azathioprine 100 mg, a well-established immunosuppressant medication widely used in the management of autoimmune diseases and prevention of organ transplant rejection. It works by suppressing abnormal immune responses that cause tissue damage and chronic inflammation.

Azathioprine interferes with purine synthesis, leading to reduced proliferation of immune cells such as lymphocytes. This controlled immunosuppression helps in reducing disease activity in conditions like rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, and autoimmune hepatitis.

In transplant medicine, Azathioprine plays a crucial role in preventing graft rejection by lowering the body’s immune response against transplanted organs. Its long-term use is supported by extensive clinical experience and well-defined dosing protocols.

Azathipair 100 Tablet is generally administered under medical supervision with routine monitoring to ensure optimal efficacy and safety, making it a trusted choice for chronic immunosuppressive therapy.

Read More

About the Product

Azathipair 100 Tablet contains Azathioprine 100 mg, a well-established immunosuppressant medication widely used in the management of autoimmune diseases and prevention of organ transplant rejection. It works by suppressing abnormal immune responses that cause tissue damage and chronic inflammation.

Azathioprine interferes with purine synthesis, leading to reduced proliferation of immune cells such as lymphocytes. This controlled immunosuppression helps in reducing disease activity in conditions like rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, and autoimmune hepatitis.

In transplant medicine, Azathioprine plays a crucial role in preventing graft rejection by lowering the body’s immune response against transplanted organs. Its long-term use is supported by extensive clinical experience and well-defined dosing protocols.

Azathipair 100 Tablet is generally administered under medical supervision with routine monitoring to ensure optimal efficacy and safety, making it a trusted choice for chronic immunosuppressive therapy.

Common side effects may include nausea, vomiting, loss of appetite, and mild gastrointestinal discomfort. Less commonly, it may cause bone marrow suppression, increased risk of infections, liver enzyme abnormalities, or hypersensitivity reactions.

Azathipair 100 Tablet is indicated for autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease (Crohn’s disease and ulcerative colitis), autoimmune hepatitis, and for prevention of organ transplant rejection.

Azathipair 100 Tablet should be used strictly under medical supervision. Regular monitoring of blood counts and liver function tests is essential during therapy. Patients should inform their doctor about any signs of infection, unusual bruising, or bleeding. Not recommended during pregnancy unless clearly advised by a physician.

Store below 25°C in a cool and dry place. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation